Inactive Instrument

Analyst Reco. Zynex Inc. Other OTC

Equities

US98986M1036

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RBC Raises Price Target on Zynex to $15 From $13, Keeps Outperform Rating	01/03	MT
RBC Initiates Zynex at Outperform With $13 Price Target, Cites 'Favorable' Financial Profile, 'Attractive Risk-Reward'	16/23/16	MT
Ladenburg Thalmann Adjusts Price Target on Zynex to $28 From $27, Maintains Buy Rating	28/23/28	MT
Piper Sandler Upgrades Zynex to Overweight From Neutral, Adjusts Price Target to $18 From $10	06/23/06	MT
B. Riley Raises Zynex's Price Target to $12.50 From $11, Notes Solid Q3 Execution with Momentum Expected Into Q4; Keeps Buy Rating	28/22/28	MT
HC Wainwright Lifts Price Target on Zynex to $21 From $20, Maintains Buy Rating	28/22/28	MT
Piper Sandler Adjusts Price Target on Zynex to $10 From $7, Maintains Neutral Rating	28/22/28	MT
B. Riley Lifts Zynex's Price Target to $11 from $10, Notes 'Solid' Q2 Results with Momentum Expected to Continue in H2; Keeps Buy Rating	29/22/29	MT
B. Riley Lowers Zynex's Price Target to $10 from $15.50, Reiterates Buy Rating	28/22/28	MT
HC Wainwright Lowers Zynex's Price Target to $20 From $22, Maintains Buy Rating	25/22/25	MT
Piper Sandler Adjusts Price Target on Zynex to $7 From $13, Maintains Neutral Rating	25/22/25	MT
B. Riley Lowers Zynex's PT to $15.50 from $19.50, Updates Model to Account for Dividends, Krestel Labs Acquisition; Keeps Buy Rating	27/21/27	MT
ZYNEX : HC Wainwright Adjusts Price Target on Zynex to $22 From $25, Reiterates Buy Rating	30/21/30	MT
ZYNEX : B. Riley Upgrades Zynex to Buy from Neutral on Q2 Order Growth, Increased EBITDA Guide; Raises PT to $19.50 from $19	16/21/16	MT
ZYNEX : Northland Securities Upgrades Zynex to Outperform From Market Perform, Sets $22.50 Price Target	09/21/09	MT
ZYNEX : B. Riley Downgrades Zynex to Neutral from Buy on Deteriorating Profitability, Increased Uncertainty; Lowers Price Target to $19 from $23	26/21/26	MT
ZYNEX : Piper Sandler Downgrades Zynex to Neutral From Overweight, Adjusts Price Target to $20 From $28	29/21/29	MT
ZYNEX : Northland Downgrades Zynex to Market Perform From Outperform, Maintains Price Target at $22.50	28/21/28	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Our Free Content Help you Secure and Increase the Performance of Your Investments

Secure my Investments

fermer